Target intelligence / Profile preview

Stimulated by retinoic acid 6 (STRA6)

Target
STRA6
Molecular classification
Receptor, Membrane protein, Transporter (uniquely, STRA6 is an atypical transporter with receptor and channel-like properties)
01

Overview

The **stimulated by retinoic acid 6** receptor (**STRA6**) is a multi-pass membrane protein that functions as the principal cell-surface receptor for plasma retinol-binding protein (RBP), facilitating the uptake of vitamin A (retinol) from the blood into specific target cells. STRA6 is most critical in the retina for the visual cycle, but is also expressed in other tissues. STRA6 binding to holo-RBP regulates vitamin A availability for developmental, metabolic, and visual functions. Mutations in STRA6 cause a spectrum of developmental disorders including anophthalmia, cardiac defects, and mental retardation. Elevated circulating RBP can signal through STRA6 to impair insulin action, linking it to metabolic syndrome.

Other names
STRA6vitamin A receptorRBP receptorretinol-binding protein receptorretinol-transporter receptor
02

Mechanism of action

Facilitates uptake of vitamin A from retinol-binding protein into cells; Receptor binding of holo-RBP triggers vitamin A internalization and can activate intracellular signaling; STRA6-mediated JAK/STAT pathway activation in some tissues

03

Biological functions

Vitamin A transport (cellular uptake of retinol from RBP)Visual cycle function (eye-specific retinoid uptake)Signal transduction (activation of JAK/STAT pathway upon ligand binding)Regulation of insulin sensitivity
04

Disease associations

Congenital eye malformations (anophthalmia, microphthalmia)Developmental defects (mental retardation, congenital heart/lung defects)Insulin resistance/metabolic syndrome
05

Safety considerations

Excess or deficiency of vitamin A can cause toxicity or developmental disordersDysfunction can lead to congenital malformations or systemic metabolic effects
06

Interacting drugs

None currently approved as direct STRA6 modulators; potential therapeutic agents considered in research for metabolic and ophthalmic disorders (vitamin A derivatives)
07

Biomarkers

STRA6 expression (for vitamin A uptake disorders, some developmental syndromes)

Beyond the preview

Go deeper on Stimulated by retinoic acid 6 (STRA6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stimulated by retinoic acid 6 (STRA6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call